The American Journal of Surgery
Volume 196, Issue 6 , Pages 851-856 , December 2008

Selective use of intraoperative sentinel lymph node pathological evaluation in breast cancer

Received 2 May 2008 ,Revised 3 June 2008

References 

  1. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–888[CrossRef] [PubMed]
  2. Ozmen V, Cabioglu N. Sentinel lymph node biopsy for breast cancer: current controversies. Breast J. 2006;12(suppl 2):S134–S142[CrossRef] [PubMed]
  3. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553[CrossRef] [PubMed]
  4. Alkhatib W, Connor C, Fang F. Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection. Am J Surg. 2007;194:856–859[CrossRef] [PubMed]
  5. Benson JR. Querci della Rovere G (Management of the axilla in women with breast cancer). Breast. 2007;16:130–136[CrossRef] [PubMed]
  6. Park J, Fey JV, Naik AM, et al. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg. 2007;245:462–468[CrossRef] [PubMed]
  7. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140–1151[CrossRef] [PubMed]
  8. Domenech A, Benitez A, Bajen MT, et al. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow—up study of up to 5 years. Oncology. 2007;72:27–32[CrossRef] [PubMed]
  9. Bergkvist L, de Boniface J, Jonsson PE, et al. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish multicenter Cohort Study. Ann Surg. 2008;247:150–156[PubMed]
  10. Chagpar AB, Carlson DJ, Laidley AL, et al. Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer. Am J Surg. 2007;194:860–865[CrossRef] [PubMed]
  11. Chagpar AB, Scoggins CR, Martin RC, et al. Are 3 sentinel nodes sufficient?. Arch Surg. 2007;142:456–460[CrossRef] [PubMed]
  12. Brogi E, Torres-Matundan E, Tan LK, et al. The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol. 2005;12:173–180[CrossRef] [PubMed]
  13. Chan SW, LaVigne KA, Port ER, et al. Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?. Ann Surg. 2008;247:143–149[PubMed]
  14. Bevilacqua JL, Kattan MW, Fey JV, et al. Doctor, what are my chances of having a positive sentinel node? (A validated nomogram for risk estimation). J Clin Oncol. 2007;25:3670–3679[CrossRef] [PubMed]
  15. Hwang RF, Gonzalez-Angulo AM, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110:723–730[CrossRef] [PubMed]

PII: S0002-9610(08)00639-9

doi: 10.1016/j.amjsurg.2008.07.027

The American Journal of Surgery
Volume 196, Issue 6 , Pages 851-856 , December 2008

Article Tools